Innovation & intellectual property · 08/10/2004Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Ranolazine Patent
Summary
The U.S. Patent and Trademark Office has issued a certificate for a second one-year extension of the term of the Ranolazine patent, bringing the total extension period to two years.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →